Johnson & Johnson (JNJ) - 재무정보
| 연도 | 매출 | 영업이익 | EPS | 부채비율(%) | PER |
|---|---|---|---|---|---|
| FY2021 | $78.74B | $20.94B | $7.81 | 145.9% | 19.48 |
| FY2022 | $79.99B | $21.01B | $6.73 | 144.0% | 24.43 |
| FY2023 | $85.16B | $23.41B | $13.72 | 143.6% | 11.01 |
| FY2024 | $88.82B | $22.15B | $5.79 | 151.9% | 24.16 |
| 연도 | 매출 | 영업이익 | EPS | 부채비율(%) | PER |
|---|---|---|---|---|---|
| FY2021 | $78.74B | $20.94B | $7.81 | 145.9% | 19.48 |
| FY2022 | $79.99B | $21.01B | $6.73 | 144.0% | 24.43 |
| FY2023 | $85.16B | $23.41B | $13.72 | 143.6% | 11.01 |
| FY2024 | $88.82B | $22.15B | $5.79 | 151.9% | 24.16 |